Unknown

Dataset Information

0

ACE2-targeting monoclonal antibody as potent and broad-spectrum coronavirus blocker.


ABSTRACT: The evolution of coronaviruses, such as SARS-CoV-2, makes broad-spectrum coronavirus preventional or therapeutical strategies highly sought after. Here we report a human angiotensin-converting enzyme 2 (ACE2)-targeting monoclonal antibody, 3E8, blocked the S1-subunits and pseudo-typed virus constructs from multiple coronaviruses including SARS-CoV-2, SARS-CoV-2 mutant variants (SARS-CoV-2-D614G, B.1.1.7, B.1.351, B.1.617.1, and P.1), SARS-CoV and HCoV-NL63, without markedly affecting the physiological activities of ACE2 or causing severe toxicity in ACE2 "knock-in" mice. 3E8 also blocked live SARS-CoV-2 infection in vitro and in a prophylactic mouse model of COVID-19. Cryo-EM and "alanine walk" studies revealed the key binding residues on ACE2 interacting with the CDR3 domain of 3E8 heavy chain. Although full evaluation of safety in non-human primates is necessary before clinical development of 3E8, we provided a potentially potent and "broad-spectrum" management strategy against all coronaviruses that utilize ACE2 as entry receptors and disclosed an anti-coronavirus epitope on human ACE2.

SUBMITTER: Chen Y 

PROVIDER: S-EPMC8385704 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8409651 | biostudies-literature
| S-EPMC3372189 | biostudies-literature
| S-EPMC4518248 | biostudies-literature
| S-EPMC113953 | biostudies-literature
| S-EPMC8983325 | biostudies-literature
| S-EPMC7402641 | biostudies-literature
| S-EPMC7048180 | biostudies-literature
| S-EPMC4547275 | biostudies-literature
| S-EPMC7103675 | biostudies-literature
| S-EPMC7673538 | biostudies-literature